Children's Hospital Los Angeles — Los Angeles, California

Public research footprint of Children's Hospital Los Angeles, compiled from the ClinicalTrials.gov public registry.

817

Registered studies

272

Active

129

Recruiting now

463

Completed

Stopped or withdrawn

Most-studied conditions

Recurrent B Acute Lymphoblastic Leukemia · Botryoid-Type Embryonal Rhabdomyosarcoma · Spindle Cell Rhabdomyosarcoma · Alveolar Rhabdomyosarcoma

Recently updated registry entries

NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT04616560 — Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory… (Recruiting)
NCT03394365 — A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Children's Hospital Los Angeles?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.